Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company ...

Get a Free Sample PDF copy of the report @- https://reportocean.com/industry-verticals/sample-request?report_id=BWC86 ...

Lynn Cole was in a never-ending cycle of getting recurrent blood infections. And no antibiotic drugs managed to kill off her zombie-like bacteria. “It just got so frustrating over the years because we ...

BiomX ( ($PHGE) ) has issued an announcement. On October 16, 2025, BiomX Inc. held its Annual Meeting of Stockholders, where all proposed business ...

Who is Attending Targeting Phage Therapy 2023? Industrial participants: Armata Pharmaceuticals (USA), Cellexus (UK), Aparon (UK), AusHealth (Australia), Biochimpharm ...

Phages, or bacteriophages, are viruses that kill certain bacteria. They occur naturally all over the world – in the soil, water, and even in your body. They can fight off bacteria that aren’t able to ...

GAITHERSBURG, Md.--(BUSINESS WIRE)--Adaptive Phage Therapeutics, Inc. (“APT”), a clinical-stage biotechnology company dedicated to providing therapies to treat infectious diseases, today announced ...

Armata Pharmaceuticals Inc.’s recent $15 million award for a three-year program from the U.S. Department of Defense to partially fund a phase Ib/II study added to the already growing resurgence of ...

GAITHERSBURG, Md.--(BUSINESS WIRE)--Adaptive Phage Therapeutics, Inc. (“APT”), a clinical-stage biotechnology company dedicated to providing therapies to treat infectious diseases, today announced ...

The 6 th World Congress on Targeting Phage Therapy 2023, being held on June 1-2 in Paris, will include more than 70 communications highlighting the most recent advances in phage and phage therapy.